Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Warren

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
The British Journal of Dermatology|March 8, 2011
A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2/IL21R B Warren, R L Smith, E Flynn, et al.
The British Journal of Dermatology|March 17, 2021
Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional studyZ Z N Yiu, G Harding-Oredugba, C E M Griffiths, et al.
The British Journal of Dermatology|September 1, 2018
Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasisC Leonardi, K Papp, B Strober, et al.
The British Journal of Dermatology|August 4, 2016
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016R B Warren, S C Weatherhead, C H Smith, et al.
The British Journal of Dermatology|March 30, 2020
Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research DatalinkZ Z N Yiu, R Parisi, M Lunt, et al.
The British Journal of Dermatology|November 25, 2017
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumabR B Warren, A Brnabic, D Saure, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 28, 2014
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective studyK Reich, I Zschocke, H Bachelez, et al.
Clinical and Experimental Dermatology|October 24, 2020
An evaluation of dermatology patients shielding during the COVID-19 outbreakS S Khan, C L Marshall, K A Stylianou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 27, 2013
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasisU Mrowietz, E M G J de Jong, K Kragballe, et al.
The British Journal of Dermatology|March 17, 2017
A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)K Reich, I Zschocke, H Bachelez, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
The British Journal of Dermatology|March 8, 2011
A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2/IL21R B Warren, R L Smith, E Flynn, et al.
The British Journal of Dermatology|March 17, 2021
Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional studyZ Z N Yiu, G Harding-Oredugba, C E M Griffiths, et al.
The British Journal of Dermatology|September 1, 2018
Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasisC Leonardi, K Papp, B Strober, et al.
The British Journal of Dermatology|August 4, 2016
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016R B Warren, S C Weatherhead, C H Smith, et al.
The British Journal of Dermatology|March 30, 2020
Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research DatalinkZ Z N Yiu, R Parisi, M Lunt, et al.
The British Journal of Dermatology|November 25, 2017
Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumabR B Warren, A Brnabic, D Saure, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 28, 2014
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective studyK Reich, I Zschocke, H Bachelez, et al.
Clinical and Experimental Dermatology|October 24, 2020
An evaluation of dermatology patients shielding during the COVID-19 outbreakS S Khan, C L Marshall, K A Stylianou, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 27, 2013
A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasisU Mrowietz, E M G J de Jong, K Kragballe, et al.
The British Journal of Dermatology|March 17, 2017
A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)K Reich, I Zschocke, H Bachelez, et al.
Pageof 12